- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2010
- Public Summary Document (PSD) July 2010 PBAC Meeting - PDF
Everolimus – July 2010
EVEROLIMUS, tablets, 5 mg and 10 mg, Afinitor®
Last updated
20 October 2010